All Relations between dopaminergic and dopamine

Publication Sentence Publish Date Extraction Date Species
C A Altar, M R Marien, J F Marshal. Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury. Journal of neurochemistry. vol 48. issue 2. 1987-02-19. PMID:3794713. this mobilization of dopaminergic function could contribute to the recovery from the behavioral deficits of partial denervation by increasing the availability of dopamine to neostriatal dopamine receptors. 1987-02-19 2023-08-11 rat
K Kamata, S Okuyama, S Hashimoto, H Aihara, Y Kasuy. Further dopaminergic supersensitivity to dopamine agonists by subchronic administration of haloperidol in rats treated with colchicine. Japanese journal of pharmacology. vol 42. issue 2. 1987-02-19. PMID:3795627. further dopaminergic supersensitivity to dopamine agonists by subchronic administration of haloperidol in rats treated with colchicine. 1987-02-19 2023-08-11 rat
A M Graybiel, E C Hirsch, Y A Agi. Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity. Proceedings of the National Academy of Sciences of the United States of America. vol 84. issue 1. 1987-02-18. PMID:2879289. these observations add to evidence that dopaminergic modulation of neural processing in the mature striatum is organized in accordance with striosomal architecture and suggest that part of the mechanism for such differentiation may involve presynaptic differences in enzymatic regulation of dopamine content in and out of striosomes. 1987-02-18 2023-08-11 human
I C Kilpatrick, O T Phillipso. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--I. The influence of electrical stimulation of the parafascicular nucleus on dopamine utilization. Neuroscience. vol 19. issue 3. 1987-02-05. PMID:3796823. it is argued that these indices of dopamine utilization together serve as reliable indicators of synaptic dopamine release and it is concluded that the parafascicular thalamus is capable of facilitating dopaminergic neurotransmission in the caudate-putamen by a mechanism that is probably independent of changes in dopamine cell firing rate. 1987-02-05 2023-08-11 rat
G M Gilad, V H Gilad, J M Rabe. Dopaminergic modulation of the septo-hippocampal cholinergic system activity under stress. Life sciences. vol 39. issue 25. 1987-01-30. PMID:3796199. increased dopamine uptake by septal synaptosomal preparations was taken as evidence for increased mesoseptal dopaminergic activity in response to stress. 1987-01-30 2023-08-11 rat
V De Leo, F Petraglia, S Sardelli, S Danero, A R Genazzani, N D'Anton. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma. Obstetrics and gynecology. vol 69. issue 1. 1987-01-29. PMID:3099236. in prolactinoma patients, the unresponsiveness of prolactin (prl) to dynamic tests with thyrotropin-releasing hormone (trh) or dopamine agonist or antagonist drugs suggests that the disease is caused by the failure of central dopaminergic inhibition. 1987-01-29 2023-08-11 Not clear
M Selmanoff, R C Walovitch, G E Walker, E D Londo. Effects of hyperprolactinemia on plasma prolactin and glucose and on local cerebral glucose utilization. Journal of neurochemistry. vol 48. issue 1. 1987-01-29. PMID:3491876. elevated blood levels of prolactin increase the synthesis, turnover, and release of 3,4-dihydroxyphenylethylamine (dopamine) from the tuberoinfundibular dopaminergic neurons, which project to the median eminence. 1987-01-29 2023-08-11 rat
M L Vargas, J A Martinez, M V Milané. Pharmacological evidence for the existence of interactions between dopaminergic and opioid peptidergic systems in guinea-pig ileum myenteric plexus. European journal of pharmacology. vol 128. issue 3. 1987-01-27. PMID:3024995. these findings would indicate that the interruption of dopaminergic transmission in the myenteric plexus produces an increase in the release of opioid peptides and suggest an inhibitory modulation of opioid peptidergic neurons by dopamine systems at this level. 1987-01-27 2023-08-11 Not clear
C F Saller, A I Salam. 3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds. Naunyn-Schmiedeberg's archives of pharmacology. vol 334. issue 2. 1987-01-15. PMID:2878374. the accumulation of 3-methoxytyramine (3-mt), the o-methylated metabolite of dopamine (da), in rat striatum was used to assess the effects of drugs on dopaminergic activity. 1987-01-15 2023-08-11 rat
M A Riddle, J F Leckman, D J Cohen, M Anderson, S I Ort, K A Caruso, B A Shaywit. Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration. Journal of neural transmission. vol 67. issue 1-2. 1987-01-15. PMID:3465864. central dopaminergic (da) function in children and adults was assessed by monitoring plasma-free levels of the dopamine metabolite homovanillic acid (phva) before and after a single oral dose and chronic oral administration of debrisoquin. 1987-01-15 2023-08-11 human
M Andrejak, L Har. Enhanced dopamine renal responsiveness in patients with hypertension. Clinical pharmacology and therapeutics. vol 40. issue 6. 1987-01-14. PMID:3780122. the purpose of the study was to compare the renal effects of low doses of exogenous dopamine to assess the responsiveness of renal dopaminergic receptors in normotensive and hypertensive subjects. 1987-01-14 2023-08-11 human
M Andrejak, L Har. Enhanced dopamine renal responsiveness in patients with hypertension. Clinical pharmacology and therapeutics. vol 40. issue 6. 1987-01-14. PMID:3780122. this enhanced response to exogenous dopamine can be considered as a further argument favoring the existence of a deficit in dopaminergic activity during hypertension. 1987-01-14 2023-08-11 human
J Knol. [Medicamentous strategy for improving the quality of life in the senescence]. Wiener medizinische Wochenschrift. Supplement. vol 98. 1987-01-05. PMID:3097965. the striatum, in which the nigrostriatal dopaminergic neurons terminate, contains the highest amount of dopamine da) in the brain. 1987-01-05 2023-08-11 human
M Steinhausen, S Weis, J Fleming, R Dussel, N Parek. Responses of in vivo renal microvessels to dopamine. Kidney international. vol 30. issue 3. 1986-12-31. PMID:3023735. these data indicate that the dilator effect of dopamine is mediated by interactions with specific dopaminergic receptors, while alpha and beta adrenergic receptors appear to mediate a constrictor influence observed with high dopamine concentrations. 1986-12-31 2023-08-11 Not clear
L Zichella, P Falaschi, P Fioretti, G B Melis, A Cagnacci, M Gambacciani, S Mancin. Effects of different dopamine agonists and antagonists on post-menopausal hot flushes. Maturitas. vol 8. issue 3. 1986-12-31. PMID:3784919. a direct dopaminergic action is hypothesized in the case of bromocriptine and liposom, while the antidopaminergic drugs might act through different indirect mechanisms such as the short-loop feedback exerted by hyperprolactinaemia on tuberoinfundibular dopamine (tida) neurons with a secondary dopamine-like activity, or stimulation of the opioid system. 1986-12-31 2023-08-11 Not clear
H S Kim, S Iyengar, P L Woo. Opiate actions on mesocortical dopamine metabolism in the rat. Life sciences. vol 39. issue 21. 1986-12-24. PMID:3784768. the actions of parenteral morphine were examined with regard to dopamine metabolism in the mesocortical dopaminergic pathways of the rat. 1986-12-24 2023-08-11 rat
M Traub, A Reches, H R Wagner, S Fah. Reserpine-induced up-regulation of dopamine D2 receptors in the rat striatum is enhanced by denervation but not by chronic receptor blockade. Neuroscience letters. vol 70. issue 2. 1986-12-18. PMID:2946007. compensatory increases in the density of dopamine (da) d2 receptors in the rat striatum occur following chronic interruption of dopaminergic neurotransmission. 1986-12-18 2023-08-11 rat
T L Perry, V W Yong, K Jones, J M Wrigh. Manipulation of glutathione contents fails to alter dopaminergic nigrostriatal neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. Neuroscience letters. vol 70. issue 2. 1986-12-18. PMID:3490637. yet neither substance protected mice from the toxic effects of n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp) on dopaminergic nigrostriatal neurons, as shown by marked depletion of striatal dopamine content when animals were sacrificed. 1986-12-18 2023-08-11 mouse
W C Koller, J Z Fields, J H Gordon, M J Perlo. Evaluation of ciladopa hydrochloride as a potential anti-Parkinson drug. Neuropharmacology. vol 25. issue 9. 1986-12-12. PMID:3774130. the effects of the putative dopamine agonist, ciladopa hydrochloride (ay 27,110) a non-ergot compound, were investigated in animal models of dopaminergic activity to evaluate its possible role in the treatment of parkinson's disease. 1986-12-12 2023-08-11 rat
W C Koller, J Z Fields, J H Gordon, M J Perlo. Evaluation of ciladopa hydrochloride as a potential anti-Parkinson drug. Neuropharmacology. vol 25. issue 9. 1986-12-12. PMID:3774130. these data indicate that ciladopa can cause stimulation of central dopaminergic receptors and that the drug is a partial dopamine agonist with direct-acting properties. 1986-12-12 2023-08-11 rat